Autopsy report · NCT00518869

Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue

“Sponsor's decision”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 3 months before it stopped.
• 13 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

PhytoHealth Corporation

Sponsor type

Industry

Conditions

Quality of Life; Fatigue; Complementary

Interventions

PG2

Participants

13

Sites

10

Countries

Taiwan

Trials that died the same way

• Everolimus With and Without Temozolomide in Adult Low Grade Glioma
  “Sponsor decision” (98% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.